产品说明

一般描述

A novel Ca²⁺-independent and reversible inhibitor of phospholipase A₂ (PLA₂; IC₅₀ = 3.8 µM). May also inhibit Ca²⁺-dependent PLA₂ at much higher concentrations (IC₅₀ = 45 µM).
A novel Ca²⁺-independent phospholipase A₂ inhibitor (IC₅₀ = 3.8 µM). May also inhibit Ca²⁺-dependent phospholipase A₂ at higher concentrations (IC₅₀ = 45 µM)

包装

5 mg in Plastic ampoule

生化/生理作用

Product does not compete with ATP.
Target IC₅₀: 3.8 µM and 45 µM against phospholipase A2 (PLA2) and Ca2+-dependent PLA2, respectively.
Cell permeable: no
Reversible: yes

警告

Toxicity: Standard Handling (A)

重悬

Supplied as a solution in ethanol. To change the solvent, evaporate the ethanol with a stream of nitrogen and immediately reconstitute with the solvent of choice. Soluble in DMSO (30 mg/ml). Only minimally soluble in aqueous buffers; do not use basic buffers; unstable at basic pH.
Following reconstitution in DMSO, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C. Product has a very low melting point. The product will change from a solid to a liquid if held in your hand or kept at room temperature or warmer for any period of time. It is best to keep the product cool while in use by placing it in the refrigerator or on ice during experimentation. Once diluted in buffer, do not store in aqueous solutions for >1 day.

其他说明

Conde-Frieboes, K., et al. 1996. J. Am. Chem. Soc. 118, 5519.
Lio, Y.C., et al. 1996. Biochim. Biophys. Acta 1302, 55.
Ackermann, E.J., et al. 1995. J. Biol. Chem.270, 445.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

基本信息

产品性质

安全信息